Pharmaceutical

Image

Global Cholera Vaccines Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cholera Vaccines Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 95.22 Million
Diagram Market Size (Forecast Year) USD 191.13 Million
Diagram CAGR %

Global Cholera Vaccines Market, By Type (Dukoral, Shanchol, Euvichol), Route of Administration (Oral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Cholera Vaccines Market Analysis and Size

An estimated 1.3 to 4.0 million cases of cholera are witnessed each year, with 21,000 to 1,43,000 deaths globally. In this regard, cholera vaccines are much in use. Several major market players are producing efficient and cost-effective cholera vaccines, which is estimated to boost the growth of the market. As cholera is a well-known public health threat, the governments are making major investments to provide improved water and sanitation facilities to the least privileged population, which remains largely affected by the disease because of poor sanitation.

Data Bridge Market Research analyses a growth rate in the cholera vaccines market in the forecast period 2023-2030. The expected CAGR of cholera vaccines market is around 9.1% in the mentioned forecast period. The market was valued at USD 95.22 million in 2022, and it would grow upto USD 191.13 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cholera Vaccines Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Dukoral, Shanchol, Euvichol), Route of Administration (Oral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Valneva SE. (France), EMERGENT (U.S.), Astellas Pharma Inc. (Japan), Sanofi (France), EUBIOLOGICS CO., LTD (South Korea), Johnson & Johnson Services Inc. (India), Celldex Therapeutics.(U.S.), Merck & Co., Inc. (U.S.), GSK plc (U.K.)

Market Opportunities

  • Rising Demand of Dukoral
  • Increasing Awareness About the Disease

Market Definition

Cholera is a type of infectious disease caused by ingesting food and water contaminated with the bacterium named as vibrio cholera. The infection has short incubation period from few hours to five days. Cholera can be fatal sometimes. The cholera vaccine inserts a small dose of live cholera bacteria in the body which helps to develop immunity against the disease. It can be given orally, intradermally or intramuscularly in the body.

Cholera Vaccines Market Dynamics

Drivers

  • Rising Incidence of Cholera Cases

As per the WHO statistics, an estimated 1.3 to 4.0 million cases of cholera are witnessed every year. The disease impacts any age group starting from children as well as adults and can result in death, if left untreated. Cholera is associated to the decreased availability of clean water and sanitation facilities. In this regard, the WHO Global Task Force on Cholera Control (GTFCC) a program aimed at controlling the spread of cholera by 2030, was launched to decrease the mortality risk related with the disease by 90% in cholera prone areas such as Asia and Africa. This is contributing to the increased demand for cholera vaccines worldwide.

Opportunities

  • Rising Demand of Dukoral

Dukoral is projected to hold a major share of the market. Dukoral is the only oral (drinkable) vaccine available in the market, that provides protection against diseases such as cholera and diarrhoea caused by Enterotoxigenic E. coli (ETEC) which is contributes somewhat to increasing the market growth. Additionally, Dukoral can be given to adults and children 2 years of age and older. Besides this, the increasing population in the cholera endemic region as well as the individuals travelling to the said region are also estimated to boost the segment growth in the upcoming years.

  • Increasing Awareness About the Disease

The growing concerns associated with cholera outbreaks and the advent of new strains which might be of greater severity are leading to a rise in R&D activities by both government and private bodies. The increasing awareness related to the vaccines and the increased availability of oral vaccines in the region are also projected to boost the market growth in the coming years. The wide adoption of water, sanitation, and hygiene practices has proven to be effective in protecting the population, combined with the use of oral cholera vaccines (OCVs).

 Restraints/Challenges

  • Longer time required for production of vaccine

The time required to complete a batch of vaccine is pretty long and thus can work as a restrict to the market. The time varies slightly as a function of production scale and varies from 41 h in case of the 1 L scale process to 48.2 h in case of the 30 L scale process. Thus, it restricts the market growth.

  • High Cost For Drug Development

The current treatment options for cholera vaccines are limited to antibiotics, and numerous pharmaceutical companies are presently focusing on developing non-antibiotic alternatives. Developing a new class of drugs will offer many growth opportunities for key players, but it will also essentially require major investments in R&D activities of novel therapies. The considerably high investment requirements may act as an obstacle to market growth.  

This cholera vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cholera vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cholera Vaccines Market Scope

The cholera vaccines market is segmented on the basis of type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Dukoral
  • Shanchol
  • Euvichol

Route of Administration

  • Oral

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Cholera Vaccines Market Regional Analysis/Insights

The cholera vaccines market is analyzed and market size insights and trends are provided by type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the cholera vaccines market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for cholera vaccines market throughout the forecasted period due to the presence of key commodity production, high research and development and healthcare expenditure and trained practitioners.  

Asia-Pacific dominates the market due to an increased prevalence of chronic diseases and poor sanitation conditions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Cholera Vaccines Market Share Analysis

The cholera vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cholera vaccines market.

Key players operating in the cholera vaccines market include:

  • Valneva SE. (France)
  • EMERGENT (U.S.)
  • Astellas Pharma Inc.(Japan)
  • Sanofi (France)
  • EUBIOLOGICS CO., LTD (South Korea)
  • Johnson & Johnson Services Inc. (India)
  • Celldex Therapeutics. (U.S.)
  • Merck & Co., Inc. (U.S.)
  • GSK plc (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Cholera Vaccines Market is projected to grow at a CAGR of 9.1% during the forecast period by 2030.
The future market value of the Cholera Vaccines Market is expected to reach USD 191.13 million by 2030.
The major players in the Cholera Vaccines Market are Valneva SE. (France), EMERGENT (U.S.), Astellas Pharma Inc. (Japan), Sanofi (France), EUBIOLOGICS CO., LTD (South Korea), Johnson & Johnson Services Inc. (India), Celldex Therapeutics.(U.S.), etc.
The countries covered in the Cholera Vaccines Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials